Quotient Diagnostics (Acquired) (AIM: EKF)

A1c diabetes testing at the point of care, with results in under 4 minutes.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Quotient Diagnostics (Acquired) (AIM: EKF) plus 5857 other startups.

Learn More

Learn More About Quotient Diagnostics (Acquired) (AIM: EKF)

Technology/product details

Competing Startups

More

Companies We Work With